NCT07229131 is a NA clinical trial of Acerola Juice Powder 1200 mg/day in Pollution; Exposure, sponsored by Diana SAS.

Who is sponsoring NCT07229131?

NCT07229131 is sponsored by Diana SAS.

What drugs are being tested in NCT07229131?

Interventions in NCT07229131: Acerola Juice Powder 1200 mg/day, Acerola Juice Powder 600 mg/day, Placebo.

What condition does NCT07229131 study?

NCT07229131 studies Pollution; Exposure.

Is NCT07229131 still recruiting?

NCT07229131 is currently completed. Last updated 18 February 2026.

Last reviewed 2026-02-18 · How we verify

NCT07229131

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Oral Acerola Juice Powder on Skin Beauty Parameters in Women Exposed to Environmental Stresses

Completed NA Last updated 18 February 2026

What this trial tests

NA trial testing Acerola Juice Powder 1200 mg/day in Pollution; Exposure in 108 participants. Completed in 13 February 2026.

Timeline

3 November 2025

Primary endpoint
13 February 2026

13 February 2026

Quick facts

Lead sponsor	Diana SAS
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	108
Start date	3 November 2025
Primary completion	13 February 2026
Estimated completion	13 February 2026
Sites	1 location across China

Drugs / interventions tested

Acerola Juice Powder 1200 mg/day
Acerola Juice Powder 600 mg/day
Placebo

Conditions studied

Pollution; Exposure — all drugs for Pollution; Exposure →

Sponsor

Diana SAS

Who can join

Adults 30 to 60, female only, with Pollution; Exposure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is being conducted to evaluate the efficacy and the safety of an oral acerola-based product on skin ageing parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pollution; Exposure

Currently open trials in the same condition.

NCT06386055 — Air Pollution and Physical Activity Study · NA · recruiting
NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
NCT04695093 — Children's Health in London and Luton (CHILL) · active not recruiting
NCT05557487 — Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administ · recruiting
NCT04353232 — Impact of Lifetime Exposure to Air and Noise Pollution on Cardiovascular Disease and Mortality - the AIRCARD Study. · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07229131 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diana SAS
Last refreshed: 18 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07229131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing